Response to Comments: Urine Drug Testing

This document is a response to provider comments on the Urine Drug Testing Local Coverage Determination (LCD L35724). The excerpt provided contains administrative dates (comment period 2023-04-27 to 2023-06-10; notice begins 2023-08-24; effective 2023-10-08) but does not include clinical coverage, limitation, frequency, or documentation requirements for urine drug testing. Manual review of the full LCD L35724 is required to extract clinical criteria and coverage rules.

"This document is a response to comments on Urine Drug Testing LCD L35724; comment period ran 2023-04-27 to 2023-06-10, notice period begins 2023-08-24, and LCD becomes effective 2023-10-08."

Sign up to see full coverage criteria, indications, and limitations.